Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk for Bleeding”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Not applicableLooking for participantsNCT06188585
What this trial is testing

Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding

Who this might be right for
Acute Gastrointestinal Bleeding
Medtronic - MITG 278
Not applicableLooking for participantsNCT06863155
What this trial is testing

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

Who this might be right for
Coronary Artery DiseaseIschemic Heart Disease
Fundación EPIC 500
Not applicableActive Not RecruitingNCT02843633
What this trial is testing

LEADERS FREE II: BioFreedom™ Pivotal Study

Who this might be right for
Acute Coronary SyndromeHigh Bleeding Risk
Biosensors Europe SA 1,203
Post-approval studies (Phase 4)Looking for participantsNCT07025148
What this trial is testing

Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)

Who this might be right for
Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
University of Florida 40
Not applicableActive Not RecruitingNCT05643430
What this trial is testing

ULTRA LONG: BioFreedom Ultra

Who this might be right for
Coronary Artery DiseaseHigh Bleeding Risk Patients
Biosensors Europe SA 86
Not applicableStudy completedNCT05471505
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 120,722
Not applicableStudy completedNCT03160911
What this trial is testing

The Use of Over-the-scope-clip for Prevention of Rebleeding in High Risk Peptic Ulcers

Who this might be right for
Ulcer BleedingUpper Gastrointestinal Tract Bleeding
Chinese University of Hong Kong 100
Testing effectiveness (Phase 2)Looking for participantsNCT07217899
What this trial is testing

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

Who this might be right for
Blood Loss, SurgicalBlood Loss, PostoperativeUterine Atony
University of Michigan 140
Not applicableUnknownNCT05479357
What this trial is testing

Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum Hemorrhage

Who this might be right for
Atonic Postpartum HemorrhageHigh Risk Pregnancy
Sohag University 80
Large-scale testing (Phase 3)Study completedNCT00164931
What this trial is testing

A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer

Who this might be right for
Peptic Ulcer Hemorrhage
Chinese University of Hong Kong 240
Large-scale testing (Phase 3)Looking for participantsNCT05198960
What this trial is testing

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaPrefibrotic/Early Primary Myelofibrosis+2 more
University Hospital, Brest 1,308
Post-approval studies (Phase 4)Study completedNCT01591083
What this trial is testing

The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers

Who this might be right for
Peptic Ulcer Bleeding
National Cheng-Kung University Hospital 474
Not applicableLooking for participantsNCT06276374
What this trial is testing

Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients

Who this might be right for
Carotid Artery Diseases
Woo-Keun Seo 1,556
Early research (Phase 1)Study completedNCT00001630
What this trial is testing

Treatment of Autoimmune Thrombocytopenia (AITP)

Who this might be right for
Autoimmune DiseaseAutoimmune Hemolytic AnemiaThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 29
Not applicableStudy completedNCT04546360
What this trial is testing

Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

Who this might be right for
Compensated Advanced Chronic Liver DiseaseVariceal Hemorrhage
Hepatopancreatobiliary Surgery Institute of Gansu Province 381
Not applicableLooking for participantsNCT06657326
What this trial is testing

LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients

Who this might be right for
Coronary Artery DiseaseChronic Stable AnginaUnstable Angina+2 more
Biosensors Europe SA 444
Large-scale testing (Phase 3)Study completedNCT04560218
What this trial is testing

Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT

Who this might be right for
To Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk Women
Department of Medical Services Ministry of Public Health of Thailand 135
Large-scale testing (Phase 3)Looking for participantsNCT05577988
What this trial is testing

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome

Who this might be right for
MYOCARDIAL INFARCTION
Assistance Publique - Hôpitaux de Paris 2,468
Not applicableNot Yet RecruitingNCT07354828
What this trial is testing

Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy

Who this might be right for
Acute Coronary Syndrome (ACS)High Bleeding Risk (HBR)Coronary Artery Disease (CAD)
Shenyang Northern Hospital 3,500
Not applicableLooking for participantsNCT06321757
What this trial is testing

PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients

Who this might be right for
Coronary Artery Disease
Fundación EPIC 501
Load More Results